Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Navigating compliance challenges and technology solutions under DSCSA.
March 8, 2025
By: Joe Lipari
Director of Product Lifecycle Management, Systech
The Drug Supply Chain Security Act (DSCSA), established in 2013, set a foundation for tracking and verifying pharmaceutical products across the United States. However, while the regulations have been phased in for over a decade, its regulatory requirements continue to evolve, introducing new challenges for the industry. As the landscape shifts, pharmaceutical companies, distributors and other key stakeholders must remain agile and prepared to adapt to ongoing changes to ensure compliance and safeguard the drug supply chain.
DSCSA was enacted to create a more secure and transparent pharmaceutical supply chain. Prior to its enactment, various state-level initiatives aimed to achieve similar goals. The FDA has established a phased enforcement plan for DSCSA, with specific deadlines for different stakeholders:
The end goal after all the DSCSA enforcement dates is for a fully interoperable supply chain—products serialized; data exchanged with trade partners.
Having a robust Level 4 (L4) traceability solution is critical to meet DSCSA requirements, combat counterfeiting and enhance supply chain visibility. Contract Pharma recently surveyed over 100 pharmaceutical organizations of different sizes, geographic locations and product portfolios using various L4 solutions. The findings—analyzed in this L4 Benchmark Report and referenced throughout the article—provide valuable insights into the current state of the L4 market by examining the experiences and priorities of these companies.
According to the report, 41% of surveyed companies cited manual rework processes as a major pain point, indicating that existing solutions require significant human intervention, leading to inefficiencies and increased operational costs. Additionally, 31% of respondents reported dissatisfaction with data exchange errors, a critical issue given DSCSA’s emphasis on accurate product traceability.
These findings underscore the need for wholesalers and other trading partners to brace for a potential surge in quarantined products. Many are already exploring automation solutions to minimize manual rework, streamline processes and prevent bottlenecks in the supply chain.
One of the major challenges under DSCSA is exception management. Exceptions refer to supply chain disruptions such as incorrect shipments, wrong addresses and damaged products. If exceptions are not managed within a specific Service Level Agreement (SLA), the products are quarantined and cannot continue moving through the supply chain.
Systech outlines a four-step process that allows businesses to manage exceptions quickly, whether they occur on the line, in the warehouse or across the supply chain.
Verification Router Service (VRS) is another important component of DSCSA compliance, streamlining the process of verifying pharmaceutical products in real time. By automating verification requests, VRS helps downstream trade partners efficiently track and authenticate products throughout the supply chain. This not only minimizes the risk of human error but also enables companies to quickly address issues such as returns or potential counterfeit products. As the DSCSA framework continues to evolve, implementing VRS remains a critical step in maintaining compliance and ensuring the security of the pharmaceutical supply chain.
Contract manufacturers and packagers can leverage technologies to enhance efficiency and stay ahead as the regulatory landscape matures. Seamless integration of these technologies depends on a well-managed roadmap, proactive planning and cross-functional collaboration between packaging, IT and regulatory teams. By anticipating future needs, organizations can better secure their operations, improve traceability and future-proof supply chains.
Aggregation: While not a legal requirement, aggregation has proven to be essential for many to enhance supply chain visibility and operational efficiency. It streamlines reconciliation, simplifies recalls and helps prevent diversion by linking individual units to cases and pallets. Aggregation is a must for ensuring full traceability. Those who invest now will gain a stronger, more resilient supply chain.
Data integration (APIs, cloud systems): As DSCSA compliance requires seamless data exchange among trading partners, integrating modern technologies like Application Programming Interfaces (APIs) and cloud-based systems is essential for contract manufacturers and packagers. APIs allow for real-time, automated data sharing between different stakeholders in the supply chain, which ensures that all parties have access to the same up-to-date information about each product’s status, reducing the potential for costly errors.
Cloud systems also play a key role by enabling centralized data storage and accessibility, allowing businesses to efficiently manage and analyze large volumes of supply chain data. By leveraging cloud solutions, CMOs and packaging partners can significantly lower compliance costs, enhance regulatory reporting accuracy and simplify data management processes.
Artificial intelligence (AI): Emerging AI technologies have the potential to improve efficiency and reduce errors by automating manual processes, analyzing data and predicting potential issues in the supply chain before they escalate. One example of this application is line clearance, where the use of smart cameras can augment the process of inspecting production lines to ensure they are free from contamination or residues from previous runs. By integrating AI solutions into their operations, CMOs and packagers can better detect and reduce errors while optimizing workflows as compliance becomes more robust.
As companies navigate compliance requirements and shifting deadlines, collaborating with industry partners, automating processes and leveraging innovative technology, will be essential to maintaining supply chain integrity and ensuring patients have uninterrupted access to critical medications. With 81% of surveyed companies identifying compliance reliability as a top priority, a forward-thinking approach will keep businesses compliant and operationally strong while securing supply chains and protecting patients.
Joe Lipari is Director of Product for Systech and is responsible for its serialization, traceability and brand protection product suite. Joe has successfully executed the product vision by expanding Systech’s cloud-based traceability platform to include end-to-end supply chain use cases, deploying an intelligent data layer to harvest and visualize critical packaging data and creating comprehensive, connected product roadmaps across the Systech platform.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !